Faron Pharmaceuticals Oy
FPHAF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$209.54M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $209.54 Million |
|---|---|
| Enterprise Value | $212.15 Million |
| Earnings per Share | $0 |
| Beta | 0.18 |
| Outstanding Shares | 88,518,000 |
Return
| Return on Equity | 317.25% |
|---|---|
| Return on Assets | -247.34% |
| Return on Invested Capital | -1216.45% |
Valuation & Multiples
| P/E Ratio | -3.03 |
|---|---|
| PEG | 3.04 |
| Price to Sales | - |
| Price to Book Ratio | -3.3 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -7.42 |
| Enterprise Value to Net Income | -7 |
| Total Debt to Enterprise | 0.06 |
| Debt to Equity | -1.24 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Faron Pharmaceuticals Oy
33 employees
CEO: Juho Markku Jalkanen
Established in Turku, Finland, in 2003, Faron Pharmaceuticals Oy operates as a clinical-stage biotechnology firm dedicated to the discovery and advancement of novel pharmaceutical solutions. The company's core focus lies in harnessing im...